These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10227323)

  • 1. Hormone replacement therapy and high S phase in breast cancer.
    Cobleigh MA; Norlock FE; Oleske DM; Starr A
    JAMA; 1999 Apr; 281(16):1528-30. PubMed ID: 10227323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
    Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
    Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
    Gapstur SM; Morrow M; Sellers TA
    JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
    Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
    Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy.
    Holli K; Isola J; Cuzick J
    J Clin Oncol; 1998 Sep; 16(9):3115-20. PubMed ID: 9738583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users.
    Sacchini V; Zurrida S; Andreoni G; Luini A; Galimberti V; Veronesi P; Intra M; Viale G; Veronesi U
    Ann Surg Oncol; 2002 Apr; 9(3):266-71. PubMed ID: 11923133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer after hormone replacement therapy--does prognosis differ in perimenopausal and postmenopausal women?
    Baumgärtner AK; Häusler A; Seifert-Klauss V; Schuster T; Schwarz-Boeger U; Kiechle M
    Breast; 2011 Oct; 20(5):448-54. PubMed ID: 21652211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptor status in breast cancer: effect of oral contraceptive pills and hormone replacement therapy.
    Tewari M; Pradhan S; Singh U; Shukla HS
    Breast; 2007 Oct; 16(5):540-5. PubMed ID: 17587581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy in relation to breast cancer.
    Chen CL; Weiss NS; Newcomb P; Barlow W; White E
    JAMA; 2002 Feb; 287(6):734-41. PubMed ID: 11851540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.
    Sellers TA; Mink PJ; Cerhan JR; Zheng W; Anderson KE; Kushi LH; Folsom AR
    Ann Intern Med; 1997 Dec; 127(11):973-80. PubMed ID: 9412302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
    Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study.
    Jiang Y; Xie Q; Chen R
    Clin Breast Cancer; 2022 Feb; 22(2):e206-e213. PubMed ID: 34548240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
    Würtz AM; Tjønneland A; Christensen J; Dragsted LO; Aarestrup J; Kyrø C; Overvad K; Olsen A
    Cancer Causes Control; 2012 Oct; 23(10):1711-20. PubMed ID: 22926300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.
    Salmon RJ; Ansquer Y; Asselain B; Languille O; Lesec G; Remvikos Y
    Oncol Rep; 1999; 6(3):699-703. PubMed ID: 10203618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.